cavi
bernd richter gmbh - strumentazione varia per supporto e monitoraggio dei parametri vitali - componenti accessori hardware
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leucemia, linfocitica, cronica, b-cell - agenti antineoplastici - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
somnotron 4
weinmann gerÄte fÜr medizin gmbh+co.kg - apparecchiature per pressione positiva continua
fernofrac
ferno washington inc. - sistemi e prodotti per immobilizzazione - altri
omeprazolo sandoz gmbh
sandoz gmbh - omeprazolo - omeprazolo
berny
so.se.pharm s.r.l. societa' di servizio per l'industria farmaceutica ed affini - fosfomicina - fosfomicina
kybernin p
csl behring gmbh - antitrombina iii - antitrombina iii
fibernet embolic protection system
lumen biomedical, inc - sistemi e cateteri di protezione per pta
bernini studio
led spa - apparecchiature per terapia a microonde